Erratum: Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))

H. M. Kantarjian, J. E. Cortes, D. W. Kim

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalBlood
Volume124
Issue number6
StatePublished - Aug 7 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

@article{fe0c6feec99c45bc888b9b63c23075f2,
title = "Erratum: Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))",
author = "Kantarjian, {H. M.} and Cortes, {J. E.} and Kim, {D. W.}",
year = "2014",
month = "8",
day = "7",
language = "English (US)",
volume = "124",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Erratum

T2 - Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors (Blood (2014) 123:9 1309-1318))

AU - Kantarjian, H. M.

AU - Cortes, J. E.

AU - Kim, D. W.

PY - 2014/8/7

Y1 - 2014/8/7

UR - http://www.scopus.com/inward/record.url?scp=84905718657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905718657&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84905718657

VL - 124

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -